Director at Quantum X Labs (QXL) exercises 88,675 pre-funded warrants into shares

Rhea-AI Filing Summary

Quantum X Labs Inc. director Yoresh Eliyahu exercised a pre-funded warrant to acquire 88,675 shares of common stock. The warrant had a stated exercise price of $0.0001 per share and was exercised on a cashless basis, so no shares were withheld for taxes or payment.

After the exercise, Eliyahu held 435,951 shares of Quantum X Labs common stock directly and 2,518 shares indirectly through Yoresh Capital Ltd. The filing shows an exercise-and-hold pattern, with no open-market sales reported in this transaction.

Insights

Insider transactions analyst

Director exercised pre-funded warrants into common stock and held the shares, with no open-market sale.

The filing shows Yoresh Eliyahu exercising a pre-funded warrant to obtain 88,675 Quantum X Labs common shares at an exercise price of $0.0001 per share. The warrant was settled on a cashless basis, meaning no shares were withheld or sold to fund the exercise.

Following the transaction on May 31, 2026, Eliyahu directly owned 435,951 common shares and indirectly owned 2,518 shares via Yoresh Capital Ltd. With no reported sales and derivative positions reduced to zero, this appears to be an exercise-and-hold event, a routine step in converting a derivative into equity exposure.

Insider Trade Summary

88,675 shares exercised/converted

Mixed 3 txns

Insider Yoresh Eliyahu

Role null

Type	Security	Shares	Price	Value
X	Pre-Funded Warrant to purchase common stock	88,675	$0.00	--
X	Common Stock, par value $0.0001 per share	88,675	$0.0001	$8.87
holding	Common Stock, par value $0.0001 per share	--	--	--

Holdings After Transaction: Pre-Funded Warrant to purchase common stock — 0 shares (Direct, null); Common Stock, par value $0.0001 per share — 435,951 shares (Direct, null); Common Stock, par value $0.0001 per share — 2,518 shares (Indirect, By Yoresh Capital Ltd.)

Footnotes (1)

1. On May 31, 2026, the Reporting Person exercised a pre-funded warrant to purchase 88,675 shares of common stock of Quantum X Labs Inc. The Reporting Person paid the exercise price on a cashless basis, which did not result in the withholding of any shares. The Pre-Funded Warrants will not expire until exercised in full.

Key Figures

Shares acquired via warrant exercise: 88,675 shares Warrant exercise price: $0.0001 per share Direct common shares after transaction: 435,951 shares +2 more

5 metrics

Shares acquired via warrant exercise 88,675 shares Pre-funded warrant exercise on May 31, 2026

Warrant exercise price $0.0001 per share Exercise of pre-funded warrant into common stock

Direct common shares after transaction 435,951 shares Direct ownership following May 31, 2026 exercise

Indirect common shares after transaction 2,518 shares Indirect ownership via Yoresh Capital Ltd.

Exercised pre-funded warrant balance 0 derivative securities Pre-funded warrant to purchase 88,675 shares fully exercised

Key Terms

pre-funded warrant, cashless basis, indirect ownership, Exercise of in-the-money or at-the-money derivative security

4 terms

pre-funded warrant financial

"Pre-Funded Warrant to purchase common stock"

A pre-funded warrant is a financial instrument that gives the holder the right to buy shares of a company's stock at a set price, with most of the purchase cost already paid upfront. It functions like a nearly fully paid option, allowing investors to secure shares quickly while minimizing the amount of additional money they need to invest later. This helps investors gain ownership rights efficiently, often used to avoid certain regulatory restrictions or to prepare for future stock purchases.

cashless basis financial

"paid the exercise price on a cashless basis, which did not result"

An agreement executed on a cashless basis lets a holder convert or exercise a security (like options, warrants, or conversion rights) without paying money upfront; instead the holder receives a smaller number of shares equal in value to what the cash would have purchased. Think of trading a coupon for fewer slices of a cake rather than handing over cash for the full slice. For investors, it affects how much ownership and dilution occur and avoids immediate cash outlays.

indirect ownership financial

"direct_or_indirect": "I", "nature_of_ownership": "By Yoresh Capital Ltd.""

Exercise of in-the-money or at-the-money derivative security financial

"transaction_code_description": "Exercise of in-the-money or at-the-money derivative security""

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Form 4 Insider Transactions: What Each Field Means →

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Yoresh Eliyahu

(Last) (First) (Middle)

5 RABIN STREET

(Street)

KIRYAT ONO L3 5551010

(City) (State) (Zip)

ISRAEL

(Country)

2. Issuer Name and Ticker or Trading Symbol
QUANTUM X LABS INC. [ QXL ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director		10% Owner
	Officer (give title below)		Other (specify below)

2a. Foreign Trading Symbol

3. Date of Earliest Transaction (Month/Day/Year)
05/31/2026

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Common Stock, par value $0.0001 per share	05/31/2026		X		88,675	A	$0.0001(1)	435,951	D
Common Stock, par value $0.0001 per share								2,518	I	By Yoresh Capital Ltd.(2)

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares
Pre-Funded Warrant to purchase common stock	$0.0001	05/31/2026		X			88,675	03/04/2026	(2)	Common Stock	88,675	$0	0	D

Explanation of Responses:

1. On May 31, 2026, the Reporting Person exercised a pre-funded warrant to purchase 88,675 shares of common stock of Quantum X Labs Inc. The Reporting Person paid the exercise price on a cashless basis, which did not result in the withholding of any shares.

2. The Pre-Funded Warrants will not expire until exercised in full.

	/s/ Eliyahu Yoresh	06/01/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)

FAQ

What insider transaction did Quantum X Labs (QXL) report for Yoresh Eliyahu?

Yoresh Eliyahu exercised a pre-funded warrant to acquire 88,675 shares of Quantum X Labs common stock. The exercise converted a derivative position into common shares and did not involve any open-market sale, indicating an exercise-and-hold pattern in this filing.

How many Quantum X Labs (QXL) shares does Yoresh Eliyahu hold after this Form 4?

After the transaction, Yoresh Eliyahu holds 435,951 Quantum X Labs common shares directly. He also has indirect ownership of 2,518 additional shares through Yoresh Capital Ltd., according to the reported ownership details in the Form 4 filing.

What was the exercise price of the pre-funded warrant in the Quantum X Labs (QXL) Form 4?

The pre-funded warrant was exercised at a stated price of $0.0001 per Quantum X Labs common share. The filing notes that the warrant was exercised on a cashless basis, which avoided any need to withhold or sell shares to cover the exercise price.

Did the Quantum X Labs (QXL) Form 4 show any insider share sales?

The Form 4 does not show any open-market sales by Yoresh Eliyahu. It reports a derivative exercise of 88,675 pre-funded warrant shares into common stock and a resulting increase in direct holdings, without any corresponding sale transaction code or sale-related share disposition.

What does cashless exercise mean in the Quantum X Labs (QXL) insider filing?

Cashless exercise means the insider did not pay the warrant exercise price in cash or have shares withheld. In this Quantum X Labs filing, the pre-funded warrant to buy 88,675 shares was exercised on a cashless basis, and no shares were withheld as part of the transaction.

Are any pre-funded warrants still outstanding after this Quantum X Labs (QXL) Form 4?

The reported pre-funded warrant to purchase 88,675 Quantum X Labs common shares shows zero derivative securities remaining after the exercise. This indicates that this specific pre-funded warrant position was fully exercised in the reported transaction.